A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 366-369, 2015.
Article
in English
| WPRIM
| ID: wpr-223601
ABSTRACT
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Imatinib mesylate is recommended as adjuvant therapy for GIST after surgical resection. However, drug-related adverse events are common. A 74-year-old female with metastatic GIST who was managed with imatinib experienced severe adverse events, including skin rashes, tremor, and alopecia, etc. The imatinib dose was reduced and the size of the metastatic GIST continued to decrease and adverse events showed significant improvement.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Immunohistochemistry
/
Tomography, X-Ray Computed
/
Proto-Oncogene Proteins c-kit
/
Gastrointestinal Stromal Tumors
/
Exanthema
/
Imatinib Mesylate
/
Gastrointestinal Neoplasms
/
Antineoplastic Agents
Limits:
Aged
/
Female
/
Humans
Language:
English
Journal:
The Korean Journal of Gastroenterology
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS